{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:51:12Z","timestamp":1780368672666,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T00:00:00Z","timestamp":1607731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T00:00:00Z","timestamp":1607731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is the most common neurodegenerative disease with multifactorial pathologies including A\u03b2 containing senile plaques and neurofibrillary tangles (NFT) consisted of aggregated Tau. Most of the AD patients are sporadic and the familial mutation hereditary patients are composed only 1% of all cases. However, the current AD mouse models employ mutated APP, PS1, or even Tau mutant, in order to display a portion of AD pathologies. Delta-secretase (legumain, or asparaginyl endopeptidase, AEP) simultaneously cleaves both APP and Tau and augments A\u03b2 production and Tau hyperphosphorylation and aggregation, contributing to AD pathogenesis. Here we show that \u03b4-secretase is sufficient to promote prominent AD pathologies in wild-type hAPP\/hMAPT double transgenic mice. We crossed hAPP l5 mice and hMAPT mice to generate double transgenic mouse model carrying both human wild-type APP and Tau. Compared to the single transgenic parents, these double transgenic mice demonstrated AD-related pathologies in one-year-old hAPP\/hMAPT mice. Notably, overexpression of \u03b4-secretase in hAPP\/hMAPT double-transgenic mice evidently accelerated enormous senile plaques and NFT, associated with prominent synaptic defects and cognitive deficits. Hence, \u03b4-secretase facilitates AD pathogenesis independent of any patient-derived mutation.<\/jats:p>","DOI":"10.1038\/s41419-020-03270-7","type":"journal-article","created":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T08:02:44Z","timestamp":1607760164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Delta-secretase triggers Alzheimer\u2019s disease pathologies in wild-type hAPP\/hMAPT double transgenic mice"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5670-1752","authenticated-orcid":false,"given":"Zhourui","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7657-8154","authenticated-orcid":false,"given":"Keqiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,12]]},"reference":[{"key":"3270_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","volume":"6","author":"DJ Selkoe","year":"1991","unstructured":"Selkoe, D. J. The molecular pathology of Alzheimer\u2019s disease. Neuron 6, 487\u2013498 (1991).","journal-title":"Neuron"},{"key":"3270_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14, 388\u2013405 (2015).","journal-title":"Lancet Neurol."},{"key":"3270_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/msj.20157","volume":"77","author":"DP Perl","year":"2010","unstructured":"Perl, D. P. Neuropathology of Alzheimer\u2019s disease. Mt Sinai J. Med 77, 32\u201342 (2010).","journal-title":"Mt Sinai J. Med"},{"key":"3270_CR4","first-page":"152","volume":"24","author":"M Padurariu","year":"2012","unstructured":"Padurariu, M., Ciobica, A., Mavroudis, I., Fotiou, D. & Baloyannis, S. Hippocampal neuronal loss in the CA1 and CA3 areas of Alzheimer\u2019s disease patients. Psychiatr. Danub 24, 152\u2013158 (2012).","journal-title":"Psychiatr. Danub"},{"key":"3270_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy, J. A. & Higgins, G. A. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256, 184\u2013185 (1992).","journal-title":"Science"},{"key":"3270_CR6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran, E., Mercken, M. & De Strooper, B. The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat. Rev. Drug Disco. 10, 698\u2013712 (2011).","journal-title":"Nat. Rev. Drug Disco."},{"key":"3270_CR7","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nn.4017","volume":"18","author":"K Herrup","year":"2015","unstructured":"Herrup, K. The case for rejecting the amyloid cascade hypothesis. Nat. Neurosci. 18, 794\u2013799 (2015).","journal-title":"Nat. Neurosci."},{"key":"3270_CR8","doi-asserted-by":"publisher","first-page":"101730","DOI":"10.1016\/j.pneurobio.2019.101730","volume":"185","author":"Z Wu","year":"2019","unstructured":"Wu, Z. et al. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer\u2019s disease pathology. Prog. Neurobiol. 185, 101730 (2019).","journal-title":"Prog. Neurobiol."},{"key":"3270_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/nm.3700","volume":"20","author":"Z Zhang","year":"2014","unstructured":"Zhang, Z. et al. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer\u2019s disease. Nat. Med 20, 1254\u20131262 (2014).","journal-title":"Nat. Med"},{"key":"3270_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9762","volume":"6","author":"Z Zhang","year":"2015","unstructured":"Zhang, Z. et al. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer\u2019s disease. Nat. Commun. 6, 8762 (2015).","journal-title":"Nat. Commun."},{"key":"3270_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04120-z","volume":"9","author":"ZH Wang","year":"2018","unstructured":"Wang, Z. H. et al. C\/EBPbeta regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer\u2019s disease. Nat. Commun. 9, 1784 (2018).","journal-title":"Nat. Commun."},{"key":"3270_CR12","doi-asserted-by":"publisher","unstructured":"Wu, Z. et al. C\/EBP\u03b2\/\u03b4-secretase signaling mediates Parkinson\u2019s disease pathogenesis via regulating transcription and proteolytic cleavage of \u03b1-synuclein and MAOB. Mol. Psychiatry, https:\/\/doi.org\/10.1038\/s41380-020-0687-7 (2020).","DOI":"10.1038\/s41380-020-0687-7"},{"key":"3270_CR13","doi-asserted-by":"publisher","unstructured":"Zhang, Z. et al. \u03b4-Secretase-cleaved Tau stimulates A\u03b2 production via upregulating STAT1-BACE1 signaling in Alzheimer\u2019s disease. Mol. Psychiatry, https:\/\/doi.org\/10.1038\/s41380-018-0286-z (2018).","DOI":"10.1038\/s41380-018-0286-z"},{"key":"3270_CR14","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.molcel.2017.07.018","volume":"67","author":"ZH Wang","year":"2017","unstructured":"Wang, Z. H. et al. Delta-secretase phosphorylation by SRPK2 enhances its enzymatic activity, provoking pathogenesis in Alzheimer\u2019s disease. Mol. Cell 67, 812\u2013825 e815 (2017).","journal-title":"Mol. Cell"},{"key":"3270_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99007","volume":"3","author":"ZH Wang","year":"2018","unstructured":"Wang, Z. H. et al. BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT. JCI Insight 3, e99007 (2018).","journal-title":"JCI Insight"},{"key":"3270_CR16","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1007\/s00259-018-4242-6","volume":"46","author":"A Leuzy","year":"2019","unstructured":"Leuzy, A. et al. Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer\u2019s disease. Eur. J. Nucl. Med. Mol. Imaging 46, 1152\u20131163 (2019).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"3270_CR17","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","volume":"60","author":"P Giannakopoulos","year":"2003","unstructured":"Giannakopoulos, P. et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease. Neurology 60, 1495\u20131500 (2003).","journal-title":"Neurology"},{"key":"3270_CR18","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","volume":"20","author":"L Mucke","year":"2000","unstructured":"Mucke, L. et al. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050\u20134058 (2000).","journal-title":"J. Neurosci."},{"key":"3270_CR19","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","volume":"86","author":"C Andorfer","year":"2003","unstructured":"Andorfer, C. et al. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J. Neurochem 86, 582\u2013590 (2003).","journal-title":"J. Neurochem"},{"key":"3270_CR20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0002-9440(10)63360-3","volume":"165","author":"T Bussiere","year":"2004","unstructured":"Bussiere, T. et al. Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance. Am. J. Pathol. 165, 987\u2013995 (2004).","journal-title":"Am. J. Pathol."},{"key":"3270_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","volume":"11","author":"WD Dupont","year":"1990","unstructured":"Dupont, W. D. & Plummer, W. D. Jr. Power and sample size calculations. A review and computer program. Control Clin. Trials 11, 116\u2013128 (1990).","journal-title":"Control Clin. Trials"},{"key":"3270_CR22","first-page":"11","volume":"3","author":"WWCC Fabin Han","year":"2015","unstructured":"Fabin Han, W. W. C. C. Research progress in animal models and stem cell therapy for Alzheimer\u2019s disease. J. Neurorestoratology 3, 11\u201322 (2015).","journal-title":"J. Neurorestoratology"},{"key":"3270_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijdevneu.2005.11.008","volume":"24","author":"A Alpar","year":"2006","unstructured":"Alpar, A., Ueberham, U., Bruckner, M. K., Arendt, T. & Gartner, U. The expression of wild-type human amyloid precursor protein affects the dendritic phenotype of neocortical pyramidal neurons in transgenic mice. Int J. Dev. Neurosci. 24, 133\u2013140 (2006).","journal-title":"Int J. Dev. Neurosci."},{"key":"3270_CR24","doi-asserted-by":"publisher","first-page":"7212","DOI":"10.1523\/JNEUROSCI.1450-06.2006","volume":"26","author":"C Priller","year":"2006","unstructured":"Priller, C. et al. Synapse formation and function is modulated by the amyloid precursor protein. J. Neurosci. 26, 7212\u20137221 (2006).","journal-title":"J. Neurosci."},{"key":"3270_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0306-4522(98)00410-2","volume":"90","author":"GR Dawson","year":"1999","unstructured":"Dawson, G. R. et al. Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience 90, 1\u201313 (1999).","journal-title":"Neuroscience"},{"key":"3270_CR26","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/S0306-4522(98)00645-9","volume":"90","author":"AL Phinney","year":"1999","unstructured":"Phinney, A. L. et al. No hippocampal neuron or synaptic bouton loss in learning-impaired aged beta-amyloid precursor protein-null mice. Neuroscience 90, 1207\u20131216 (1999).","journal-title":"Neuroscience"},{"key":"3270_CR27","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1093\/brain\/awl237","volume":"129","author":"L Cabrejo","year":"2006","unstructured":"Cabrejo, L. et al. Phenotype associated with APP duplication in five families. Brain 129, 2966\u20132976 (2006).","journal-title":"Brain"},{"key":"3270_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux, A. et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat. Genet 38, 24\u201326 (2006).","journal-title":"Nat. Genet"},{"key":"3270_CR29","first-page":"235","volume":"138","author":"E Masliah","year":"1991","unstructured":"Masliah, E., Terry, R. D., Alford, M., DeTeresa, R. & Hansen, L. A. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer\u2019s disease. Am. J. Pathol. 138, 235\u2013246 (1991).","journal-title":"Am. J. Pathol."},{"key":"3270_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0197-4580(92)90111-A","volume":"13","author":"WG Honer","year":"1992","unstructured":"Honer, W. G., Dickson, D. W., Gleeson, J. & Davies, P. Regional synaptic pathology in Alzheimer\u2019s disease. Neurobiol. Aging 13, 375\u2013382 (1992).","journal-title":"Neurobiol. Aging"},{"key":"3270_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.nbd.2008.11.005","volume":"33","author":"AM Simon","year":"2009","unstructured":"Simon, A. M. et al. Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Abeta levels. Neurobiol. Dis. 33, 369\u2013378 (2009).","journal-title":"Neurobiol. Dis."},{"key":"3270_CR32","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal, I. et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA 83, 4913\u20134917 (1986).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3270_CR33","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.4103\/0366-6999.220313","volume":"130","author":"XL Wu","year":"2017","unstructured":"Wu, X. L., Pina-Crespo, J., Zhang, Y. W., Chen, X. C. & Xu, H. X. Tau-mediated neurodegeneration and potential implications in diagnosis and treatment of Alzheimer\u2019s disease. Chin. Med. J. 130, 2978\u20132990 (2017).","journal-title":"Chin. Med. J."},{"key":"3270_CR34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.nlm.2010.12.005","volume":"95","author":"A Van der Jeugd","year":"2011","unstructured":"Van der Jeugd, A. et al. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Neurobiol. Learn Mem. 95, 296\u2013304 (2011).","journal-title":"Neurobiol. Learn Mem."},{"key":"3270_CR35","doi-asserted-by":"publisher","first-page":"16559","DOI":"10.1523\/JNEUROSCI.4363-10.2010","volume":"30","author":"A Boutajangout","year":"2010","unstructured":"Boutajangout, A., Quartermain, D. & Sigurdsson, E. M. Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model. J. Neurosci. 30, 16559\u201316566 (2010).","journal-title":"J. Neurosci."},{"key":"3270_CR36","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1074\/jbc.M110.199976","volume":"286","author":"A Sultan","year":"2011","unstructured":"Sultan, A. et al. Nuclear tau, a key player in neuronal DNA protection. J. Biol. Chem. 286, 4566\u20134575 (2011).","journal-title":"J. Biol. Chem."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03270-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03270-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03270-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T16:01:10Z","timestamp":1670256070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03270-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,12]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["3270"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-03270-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,12]]},"assertion":[{"value":"10 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol was reviewed and approved by the Emory Institutional Animal Care and Use Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1058"}}